Cargando…
Antivenomics and in vivo preclinical efficacy of six Latin American antivenoms towards south-western Colombian Bothrops asper lineage venoms
BACKGROUND: Bothrops asper represents the clinically most important snake species in Central America and Northern South America, where it is responsible for an estimated 50–80% of snakebites. Compositional variability among the venom proteomes of B. asper lineages across its wide range mirrors clini...
Autores principales: | Mora-Obando, Diana, Pla, Davinia, Lomonte, Bruno, Guerrero-Vargas, Jimmy Alexander, Ayerbe, Santiago, Calvete, Juan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877754/ https://www.ncbi.nlm.nih.gov/pubmed/33524033 http://dx.doi.org/10.1371/journal.pntd.0009073 |
Ejemplares similares
-
Third-generation antivenomics analysis of the preclinical efficacy of Bothrofav® antivenom towards Bothrops lanceolatus venom
por: Pla, Davinia, et al.
Publicado: (2018) -
Snake Venomics and Antivenomics of Bothrops diporus, a Medically Important Pitviper in Northeastern Argentina
por: Gay, Carolina, et al.
Publicado: (2015) -
Third Generation Antivenomics: Pushing the Limits of the In Vitro Preclinical Assessment of Antivenoms
por: Pla, Davinia, et al.
Publicado: (2017) -
Omics Meets Biology: Application to the Design and Preclinical Assessment of Antivenoms
por: Calvete, Juan J., et al.
Publicado: (2014) -
Vipera berus berus Venom from Russia: Venomics, Bioactivities and Preclinical Assessment of Microgen Antivenom
por: Al-Shekhadat, Ruslan I., et al.
Publicado: (2019)